These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 31129820

  • 1. [Trigeminal neuralgia: treatment options for refractory cases].
    Ruscheweyh R, Straube A.
    MMW Fortschr Med; 2019 May; 161(10):52-56. PubMed ID: 31129820
    [No Abstract] [Full Text] [Related]

  • 2. Botulinum toxin and intractable trigeminal neuralgia.
    Türk U, Ilhan S, Alp R, Sur H.
    Clin Neuropharmacol; 2005 May; 28(4):161-2. PubMed ID: 16062093
    [Abstract] [Full Text] [Related]

  • 3. Use of botulinum toxin A for drug-refractory trigeminal neuralgia: preliminary report.
    Bohluli B, Motamedi MH, Bagheri SC, Bayat M, Lassemi E, Navi F, Moharamnejad N.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Jan; 111(1):47-50. PubMed ID: 20674409
    [Abstract] [Full Text] [Related]

  • 4. Botulinum toxin in trigeminal neuralgia.
    Castillo-Álvarez F, Hernando de la Bárcena I, Marzo-Sola ME.
    Med Clin (Barc); 2017 Jan 06; 148(1):28-32. PubMed ID: 27743594
    [Abstract] [Full Text] [Related]

  • 5. Botulinum Toxin Type A Injections as an Effective Treatment of Refractory Multiple Sclerosis-Related Trigeminal Pain - A Case Report.
    Calejo M, Salgado P, Moreira B, Correia C, Barros J.
    Headache; 2019 Sep 06; 59(8):1379-1381. PubMed ID: 31424566
    [No Abstract] [Full Text] [Related]

  • 6. Botulinum toxin for trigeminal neuralgia.
    Nurmikko T, Cruccu G.
    Eur J Neurol; 2009 May 06; 16(5):e104. PubMed ID: 19405205
    [No Abstract] [Full Text] [Related]

  • 7. Trigeminal Neuralgia With Extraoral Trigger Zone Successfully Treated With Intraoral Injections of Botulinum Toxin: A Case Report.
    Dinan JE, Smith A, Hawkins JM.
    Clin Neuropharmacol; 2020 May 06; 43(5):162-163. PubMed ID: 32947428
    [Abstract] [Full Text] [Related]

  • 8. Botulinum toxin for trigeminal neuralgia--do we have the evidence?
    Zakrzewska JM.
    Cephalalgia; 2012 Nov 06; 32(15):1154-5; author reply 1156-7. PubMed ID: 22990690
    [No Abstract] [Full Text] [Related]

  • 9. Beneficial effects of botulinum toxin type A in trigeminal neuralgia.
    Zúñiga C, Díaz S, Piedimonte F, Micheli F.
    Arq Neuropsiquiatr; 2008 Sep 06; 66(3A):500-3. PubMed ID: 18813708
    [Abstract] [Full Text] [Related]

  • 10. Botulinum toxin-A as a treatment option for refractory idiopathic trigeminal neuralgia of the ophthalmic branch: a case report and literature review.
    Kandari A, Devaprasad BATP, Hernandez-Rivera P, Hernandez IA, Friesen R.
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2024 May 06; 137(5):e73-e82. PubMed ID: 38575452
    [Abstract] [Full Text] [Related]

  • 11. Effects of Botulinum Toxin Type A on Pain among Trigeminal Neuralgia, Myofascial Temporomandibular Disorders, and Oromandibular Dystonia.
    Yoshida K.
    Toxins (Basel); 2021 Aug 29; 13(9):. PubMed ID: 34564609
    [Abstract] [Full Text] [Related]

  • 12. BoTN-A: The efficacy of botulinum toxin for the treatment of trigeminal and postherpetic neuralgia: a systematic review with meta-analyses.
    Br Dent J; 2016 Oct 21; 221(8):475. PubMed ID: 27767141
    [Abstract] [Full Text] [Related]

  • 13. A new treatment paradigm for trigeminal neuralgia using Botulinum toxin type A.
    Guardiani E, Sadoughi B, Blitzer A, Sirois D.
    Laryngoscope; 2014 Feb 21; 124(2):413-7. PubMed ID: 23818108
    [Abstract] [Full Text] [Related]

  • 14. Beneficial effects of botulinum toxin type a for patients with painful tic convulsif.
    Micheli F, Scorticati MC, Raina G.
    Clin Neuropharmacol; 2002 Feb 21; 25(5):260-2. PubMed ID: 12410057
    [Abstract] [Full Text] [Related]

  • 15. The efficacy of botulinum toxin for the treatment of trigeminal and postherpetic neuralgia: a systematic review with meta-analyses.
    Shackleton T, Ram S, Black M, Ryder J, Clark GT, Enciso R.
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Jul 21; 122(1):61-71. PubMed ID: 27260275
    [Abstract] [Full Text] [Related]

  • 16. The efficacy and safety of botulinum toxin type A in treatment of trigeminal neuralgia and peripheral neuropathic pain: A meta-analysis of randomized controlled trials.
    Wei J, Zhu X, Yang G, Shen J, Xie P, Zuo X, Xia L, Han Q, Zhao Y.
    Brain Behav; 2019 Oct 21; 9(10):e01409. PubMed ID: 31541518
    [Abstract] [Full Text] [Related]

  • 17. Botulinum toxin - intraorally: Intraoral administration of botulinum toxin for trigeminal neuropathic pain.
    Br Dent J; 2016 Aug 12; 221(3):126. PubMed ID: 27514346
    [Abstract] [Full Text] [Related]

  • 18. Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo-controlled trial.
    Wu CJ, Lian YJ, Zheng YK, Zhang HF, Chen Y, Xie NC, Wang LJ.
    Cephalalgia; 2012 Apr 12; 32(6):443-50. PubMed ID: 22492424
    [Abstract] [Full Text] [Related]

  • 19. Botulinum toxin-type A: could it be an effective treatment option in intractable trigeminal neuralgia?
    Shehata HS, El-Tamawy MS, Shalaby NM, Ramzy G.
    J Headache Pain; 2013 Nov 19; 14(1):92. PubMed ID: 24251833
    [Abstract] [Full Text] [Related]

  • 20. Intraoral administration of botulinum toxin for trigeminal neuropathic pain.
    Herrero Babiloni A, Kapos FP, Nixdorf DR.
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Jun 19; 121(6):e148-53. PubMed ID: 27181448
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.